Pituitary apoplexy

considerations on a single center experience and review of the literature

L. Giammattei, G. Mantovani, G. Carrabba, S. Ferrero, A. Di Cristofori, E. Verrua, C. Guastella, L. Pignataro, P. Rampini, M. Minichiello, M. Locatelli

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Purpose: To present a single-center experience on pituitary tumor apoplexy and a review of literature focusing on predisposing and precipitating factors. Methods: Clinical presentation of our series of cases. Contemporary published literature is also reviewed. Results: The definition of this syndrome has not been consistent although now the majority of authors agree to definite it as an acute condition caused by hemorrhage or infarction of a pre-existing pituitary adenoma. Different predisposing and precipitating factors have been described in literature; among these antithrombotic and anticoagulant drugs, seem to play relevant roles. The clinical cases observed in our clinic confirm these data and suggest a probable association between elderly patients taking anticoagulant therapy and pituitary apoplexy adenoma. Conclusion: Pituitary tumor apoplexy remains a challenging disease in relation to difficulties in correct diagnosis and thus in appropriate treatment. Antithrombotic/anticoagulant therapy may have an important role as precipitating factor. When a pituitary disorder is known, great care should be taken in the prescription of anticoagulant therapy.

Original languageEnglish
Pages (from-to)739-746
Number of pages8
JournalJournal of Endocrinological Investigation
Volume39
Issue number7
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Pituitary Apoplexy
Pituitary Neoplasms
Precipitating Factors
Anticoagulants
Causality
Pituitary Diseases
Therapeutics
Infarction
Prescriptions
Hemorrhage

Keywords

  • Anticoagulant therapy
  • Apoplexy
  • Pituitary
  • Review

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Pituitary apoplexy : considerations on a single center experience and review of the literature. / Giammattei, L.; Mantovani, G.; Carrabba, G.; Ferrero, S.; Di Cristofori, A.; Verrua, E.; Guastella, C.; Pignataro, L.; Rampini, P.; Minichiello, M.; Locatelli, M.

In: Journal of Endocrinological Investigation, Vol. 39, No. 7, 01.07.2016, p. 739-746.

Research output: Contribution to journalReview article

@article{e5fbdc638f784aaf9b9555f0358d2b90,
title = "Pituitary apoplexy: considerations on a single center experience and review of the literature",
abstract = "Purpose: To present a single-center experience on pituitary tumor apoplexy and a review of literature focusing on predisposing and precipitating factors. Methods: Clinical presentation of our series of cases. Contemporary published literature is also reviewed. Results: The definition of this syndrome has not been consistent although now the majority of authors agree to definite it as an acute condition caused by hemorrhage or infarction of a pre-existing pituitary adenoma. Different predisposing and precipitating factors have been described in literature; among these antithrombotic and anticoagulant drugs, seem to play relevant roles. The clinical cases observed in our clinic confirm these data and suggest a probable association between elderly patients taking anticoagulant therapy and pituitary apoplexy adenoma. Conclusion: Pituitary tumor apoplexy remains a challenging disease in relation to difficulties in correct diagnosis and thus in appropriate treatment. Antithrombotic/anticoagulant therapy may have an important role as precipitating factor. When a pituitary disorder is known, great care should be taken in the prescription of anticoagulant therapy.",
keywords = "Anticoagulant therapy, Apoplexy, Pituitary, Review",
author = "L. Giammattei and G. Mantovani and G. Carrabba and S. Ferrero and {Di Cristofori}, A. and E. Verrua and C. Guastella and L. Pignataro and P. Rampini and M. Minichiello and M. Locatelli",
year = "2016",
month = "7",
day = "1",
doi = "10.1007/s40618-015-0424-2",
language = "English",
volume = "39",
pages = "739--746",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "7",

}

TY - JOUR

T1 - Pituitary apoplexy

T2 - considerations on a single center experience and review of the literature

AU - Giammattei, L.

AU - Mantovani, G.

AU - Carrabba, G.

AU - Ferrero, S.

AU - Di Cristofori, A.

AU - Verrua, E.

AU - Guastella, C.

AU - Pignataro, L.

AU - Rampini, P.

AU - Minichiello, M.

AU - Locatelli, M.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Purpose: To present a single-center experience on pituitary tumor apoplexy and a review of literature focusing on predisposing and precipitating factors. Methods: Clinical presentation of our series of cases. Contemporary published literature is also reviewed. Results: The definition of this syndrome has not been consistent although now the majority of authors agree to definite it as an acute condition caused by hemorrhage or infarction of a pre-existing pituitary adenoma. Different predisposing and precipitating factors have been described in literature; among these antithrombotic and anticoagulant drugs, seem to play relevant roles. The clinical cases observed in our clinic confirm these data and suggest a probable association between elderly patients taking anticoagulant therapy and pituitary apoplexy adenoma. Conclusion: Pituitary tumor apoplexy remains a challenging disease in relation to difficulties in correct diagnosis and thus in appropriate treatment. Antithrombotic/anticoagulant therapy may have an important role as precipitating factor. When a pituitary disorder is known, great care should be taken in the prescription of anticoagulant therapy.

AB - Purpose: To present a single-center experience on pituitary tumor apoplexy and a review of literature focusing on predisposing and precipitating factors. Methods: Clinical presentation of our series of cases. Contemporary published literature is also reviewed. Results: The definition of this syndrome has not been consistent although now the majority of authors agree to definite it as an acute condition caused by hemorrhage or infarction of a pre-existing pituitary adenoma. Different predisposing and precipitating factors have been described in literature; among these antithrombotic and anticoagulant drugs, seem to play relevant roles. The clinical cases observed in our clinic confirm these data and suggest a probable association between elderly patients taking anticoagulant therapy and pituitary apoplexy adenoma. Conclusion: Pituitary tumor apoplexy remains a challenging disease in relation to difficulties in correct diagnosis and thus in appropriate treatment. Antithrombotic/anticoagulant therapy may have an important role as precipitating factor. When a pituitary disorder is known, great care should be taken in the prescription of anticoagulant therapy.

KW - Anticoagulant therapy

KW - Apoplexy

KW - Pituitary

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=84975828006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975828006&partnerID=8YFLogxK

U2 - 10.1007/s40618-015-0424-2

DO - 10.1007/s40618-015-0424-2

M3 - Review article

VL - 39

SP - 739

EP - 746

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 7

ER -